BFM
LUNG icon

Boothbay Fund Management’s Pulmonx LUNG Stock Holding History

Boothbay Fund Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-212,980
Closed -$1.45M – 1612
2024
Q4 		$1.45M Sell
212,980
-63,206
-23% -$416K 0.04% 535
2024
Q3 		$2.29M Sell
276,186
-40,714
-13% -$295K 0.05% 479
2024
Q2 		$2.01M Buy
316,900
+90,701
+40% +$697K 0.05% 500
2024
Q1 		$2.1M Buy
226,199
+199,199
+738% +$2.34M 0.04% 490
2023
Q4 		$344K Sell
27,000
-15,000
-36% -$156K 0.01% 1140
2023
Q3 		$434K Buy
42,000
+15,000
+56% +$174K 0.01% 1093
2023
Q2 		$354K Buy
+27,000
New +$330K 0.01% 1244

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's LUNG Position: Q1 2025 in Review

Boothbay Fund Management sold out of Pulmonx (LUNG) in Q1 2025, closing a stake of 212,980 shares — an estimated $1.45M sold.

Boothbay Fund Management first reported a position in LUNG in Q2 2023 and held it in 7 quarters. The position peaked at $2.29M in Q3 2024. 115 funds tracked by Wall St. Rank hold LUNG as of Q1 2025.

  • Boothbay Fund Management reported no remaining Pulmonx position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 212,980 Pulmonx shares in Q1 2025, an estimated $1.45M.
  • Boothbay Fund Management first reported a position in Pulmonx in Q2 2023 and held it in 7 quarters.
  • Boothbay Fund Management's Pulmonx position peaked at $2.29M in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.